Nasdaq: HALO
Halozyme Therapeutics insiders
The officers, directors and 10% owners of Halozyme Therapeutics, Inc. who hold the most stock, valued at the live HALO price.
$93.04
HALO today −$2.8M (−2.88%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 6
- Their HALO stock
- $115M
- Market value
- $10.61B
- Held by ranked insiders
- 1.08%
Insiders by value of HALO holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Helen Torley | PRESIDENT AND CEO | 767,780 | $71.4M | 0.67% | 1959th |
| 2 | Connie Matsui | Director | 183,035 | $17.0M | 0.16% | 5831st |
| 3 | Michael J. LaBarre | SVP, CHIEF TECHNICAL OFFICER | 173,756 | $16.2M | 0.15% | 6059th |
| 4 | Jean-Pierre Bizzari | Director | 66,815 | $6.2M | <0.1% | 12191st |
| 5 | Jeffrey William Henderson | Director | 36,572 | $3.4M | <0.1% | 10173rd |
| 6 | David A. Ramsay | EVP, PRESIDENT, DRUG DELIVERY | 4,592 | $427K | <0.1% | 6943rd |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Halozyme Therapeutics; see each profile for the filing.